Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: zr pharma& GmbH, Hietzinger Hauptstrasse 37, 1130 Vienna, Austria
Anafranil SR 75 mg Prolonged-release Tablets.
| Pharmaceutical Form |
|---|
|
Prolonged-release, film-coated tablet. Pink, capsule shaped, biconvex, film-coated tablet, scored on both sides. One side debossed with ‘CG’ and the other ‘GD’. The tablets should not be broken. |
Each tablet contains 75 mg clomipramine hydrochloride.
Excipient with known effect: Each tablet contains 235 micrograms polyoxyl hydrogenated castor oil.
For a full list of excipients see section 6.1.
| Active Ingredient |
|---|
|
The therapeutic activity of clomipramine is believed to be based on its ability to inhibit the neuronal re-uptake of noradrenaline (NA) and serotonin (5-HT) released in the synaptic cleft, with inhibition of 5-HT reuptake being the more important of these activities. |
| List of Excipients |
|---|
|
Eudragit E30D (polyacrylate dispersion 30%) |
PVC/Aluminium blister packs in cardboard cartons.
Pack sizes of 100, 30 and 28 tablets are available.
Not all pack sizes may be marketed.
zr pharma& GmbH, Hietzinger Hauptstrasse 37, 1130 Vienna, Austria
PA23086/001/001
Date of first authorisation: 19 September 1988
Date of last renewal: 01 April 2008
| Drug | Countries | |
|---|---|---|
| ANAFRANIL | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Poland, Romania, Singapore, Tunisia, Turkey, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.